CDC approves Moderna, Pfizer-BioNTech Omicron booster shots for everyone 12 and older
Author
Blaire Bryant
Upcoming Events
Related News
Key Takeaways
On September 5, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation for updated COVID-19 boosters for everyone age 12 and up, following the Food and Drug Administration’s (FDA) approval of an emergency use authorization for the updated Pfizer-BioNTech and Moderna boosters on August 31. The boosters generate stronger immune protection against COVID-19 variants that are currently circulating widely in the U.S.
The updated emergency use authorizations permit the administration of a single booster at least two months after a primary or booster dose is given. The CDC Director, Dr. Rochelle Walensky, released a statement recommending eligibility for the Pfizer-BioNTech bivalent COVID-19 booster for people ages 12 and older and the Moderna COVID-19 booster for people ages 18 and older. The updated COVID-19 boosters add protection against the Omicron BA.4 and BA.5 variants, which currently make up nearly 90 percent of all cases of COVID-19 in the U.S. The CDC booster recommendation is for all individuals that have received at least a full primary vaccination series, which according to CDC guidance includes both a primary (2-dose) series and a one-dose booster.
The Biden administration has ordered 175 million doses of the new boosters. Pfizer plans to ship up to 15 million doses of its booster to the U.S. by September 9. Additionally, Pfizer plans to apply for an emergency use authorization for its booster to be used for children ages 5-11 in early October and is working to receive FDA approval for boosters for children under the age of 5.
The COVID-19 vaccines authorized for use in the U.S. continue to reduce the risk of severe disease, hospitalization and death, including against the Omicron variant and subvariants. As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported the administration of more than 610 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters.
ADDITIONAL RESOURCES
Resource
The County Role in Vaccines
Related News
NACo offers new Medicaid resources as Congress advances Budget Resolutions with major Medicaid reform implications
On April 10, the U.S. House of Representatives voted to adopt a Senate-passed budget resolution, marking the next step in the budget reconciliation process. The proposed funding levels therein represent significant potential cost shifts to counties, particularly in the area of Medicaid financing. To help county leaders understand what’s at stake, NACo has developed two new resources.
County Countdown – April 21, 2025
Every other week, NACo's County Countdown reviews top federal policy advocacy items with an eye towards counties and the intergovernmental partnership. This week features the ARPA reporting deadline, a budget reconciliation update and more
U.S. House reintroduces legislation to address the Medicaid Inmate Exclusion Policy
Two bipartisan bills aimed at addressing the Medicaid Inmate Exclusion Policy (MIEP) were recently reintroduced in the U.S. House of Representatives.